Treatment satisfaction, adherence and behavioral assessment in patients de – escalating from natalizumab to interferon beta

BACKGROUND: De-escalating natalizumab (NTZ) to interferon beta 1b (IFN B 1B) is a possible treatment option in multiple sclerosis (MS) patients interrupting NTZ because of increased risk of progressive multifocal leukoencephalopathy (PML). The aim of this study was to evaluate satisfaction and adher...

Descripción completa

Detalles Bibliográficos
Autores principales: Zecca, Chiara, Riccitelli, Gianna C, Calabrese, Pasquale, Pravatà, Emanuele, Candrian, Ursula, Guttmann, Charles RG, Gobbi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940251/
https://www.ncbi.nlm.nih.gov/pubmed/24576156
http://dx.doi.org/10.1186/1471-2377-14-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940251/
https://www.ncbi.nlm.nih.gov/pubmed/24576156
http://dx.doi.org/10.1186/1471-2377-14-38

Ejemplares similares